PHINMA-UNIVERSITY OF ILOILO

COLLEGE OF ALLIED HEALTH SCIENCES

Nursing Department

DRUG STUDY
THERAPEUTIC NURSING
MEDICATION INDICATIONS CONTRAINDICATIONS SIDE EFFECTS
ACTIONS RESPONSIBILITIES/PRECAUTIONS
GENERIC NAME: Baseline Assessment:
Hypersensitivity -Pt should be in recumbent position before drug is
Morphine Sulfate Principal opium Relief of -Sedation
given by parenteral route.
alkaloid; acts as to morphine. -Assess onset, type, location, duration of pain.
moderate to -Decreased B/P
agonist at specific Acute or severe -Obtain vital signs before giving medication. If
opioid receptors severe, acute, (including orthostatic respirations are 12/min or less (20/min or less in
asthma, GI hypotension) children), withhold medication, contact physician.
BRAND NAME: in the CNS to or chronic pain;
Duramorph, obstruction, -Diaphoresis -Effect of medication is reduced if full pain recurs
produce analgesia, analgesia -Facial flushing before next dose
Infumorph, euphoria, known or
during labor, -Constipation
Roxanol sedation, the suspected Intervention:
receptors mediating pain due to MI, -Dizziness -Monitor vital signs 5–10 min after IV
paralytic ileus, -Drowsiness
these effects are dyspnea from administration, 15–30 min after SQ, IM.
CLASSIFICATION: severe -Nausea -Be alert for decreased respirations, B/P.
Pharmaco-therapeutic:
thought to be the pulmonary -Vomiting
same as those hepatic/renal -Check for adequate voiding.
Opioid agonist edema not -Monitor daily pattern of bowel activity, stool
mediating the effects impairment, consistency; avoid constipation.
of endogenous resulting from
severe -Initiate deep breathing, coughing exercises,
ROUTE: opioids chemical particularly in those with pulmonary impairment.
respiratory
Oral/ IV (enkephalins, respiratory -Assess for clinical improvement, record onset of
endorphins) depression. pain relief.
irritant. -Consult physician if pain relief is not adequate.
Patient/Family Teaching:
-Discomfort may occur with injection.
DOSAGE/FREQUENCY: -Change positions slowly to avoid orthostatic
hypotension.
Oral: 10–30 mg q4h PRN -Avoid tasks that require alertness, motor skills
IV: 2.5–5 mg q3–4h PRN until response to drug is established.
-Avoid alcohol, CNS depressants.
-Tolerance, dependence may occur with
prolonged use of high doses.
-Report ineffective pain control, constipation,
urinary retention.

Tapucay, Yesha Ella M.

PREPARED BY: ________________________________ Sheryl Jane Olmos
NOTED BY: _____________________________
STUDENT’S NAME CLINICAL INSTRUCTOR